# Glycar, Inc.

- Location (FDA's records): Dallas, TX
- FDA decisions: 5 (1994–1997): 5 510(k) clearances
- Product codes: FTL (2), DXZ (2), FTM (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 4 (0 its own)
- Recalls linked to its devices: 2 (2 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Bio-Vascular, Inc.: 3 (https://510kreport.com/company/bio-vascular)

## Firms that cite its devices most
- Pm Devices, Inc.: 2 (https://510kreport.com/company/pm-devices)
- Edwards Lifesciences, LLC: 1 (https://510kreport.com/company/edwards-lifesciences)
- Cook Biotech, Inc.: 1 (https://510kreport.com/company/cook-biotech)

## Its most-cited devices
- K963967: Glycar Pericardial Patch (1997), cited by 3
- K954665: Glycar Staple Strips (1996), cited by 1

## Recent decisions
- K963368: Glycartissue Repair Patch Family of Products; Glycar Vascular Repair Patch Alternative Proprietary Name Possible (Oct 31, 1997)
- K963967: Glycar Pericardial Patch (Oct 31, 1997)
- K963175: Glycar Tissue Repair Patch, Bio-Patch, Uro-Sling (Sep 23, 1996)
- K954665: Glycar Staple Strips (Feb 14, 1996)
- K942911: Glycar Tissue Repair Patch (Dec 14, 1994)

Source page: https://510kreport.com/company/glycar